Rigel PharmaceuticalsRIGL
13F holders, Q4 2024 (December 31)6holders +2
2new positions
0sold out
$16.81avg. 13F price*
At the end of Q4 2024, 6 institutions reported holding Rigel Pharmaceuticals Inc. (RIGL) in their 13F filings, up 2 from Q3 2024. 2 opened new positions and 0 sold out. The largest holders were Farther Finance Advisors, LLC ($11K), Avior Wealth Management, LLC ($6K) and Versant Capital Management, Inc ($2K).
- Company
- Rigel Pharmaceuticals Inc.
- CUSIP
- 766559603
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $8K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 479 shares bought, net +479 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Farther Finance Advisors, LLC | 0.00% | No change | 667 | $11K |
| Avior Wealth Management, LLC | 0.00% | New | 356 | $6K |
| Versant Capital Management, Inc | 0.00% | New | 123 | $2K |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 63 | $1K |
| Hexagon Capital Partners LLC | 0.00% | No change | 2 | $34 |
| Huntington National Bank | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is RIGL's weight in each manager's 13F, not the share of Rigel Pharmaceuticals Inc. the manager owns.